Figure 2From: Administration of recombinant thrombomodulin before progression of disease causing disseminated intravascular coagulation might be better compared with administration after progression of diseaseThe relationship of time duration between the onset of disease and recombinant thrombomodulin administration with survival rate. The relationship of time duration between the onset of disease and recombinant thrombomodulin (rTM) administration (as X factor) with survival rate (as Y factor). Gray bar denotes mean survival rate, and gray line signifies mean 95% confidence interval.Back to article page